CD4+ T cell immunity against the human papillomavirus‐18 E6 transforming protein in healthy donors: identification of promiscuous naturally processed epitopes
Open Access
- 22 February 2005
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 35 (3) , 806-815
- https://doi.org/10.1002/eji.200425699
Abstract
Infection by ‘high-risk’ human papillomaviruses (HPV) is associated with the development of neoplastic lesions. HPV-18 is responsible for a very aggressive form of cancer and poor survival. As for other HPV types, immune surveillance has probably a role in the control of the infection. However, very little is known on HPV-18 immunogenicity. CD4+ T cells from 16 healthy donors were tested ex vivo for reactivity to synthetic peptides corresponding to 3 sequences on the HPV-18 E6 transforming protein predicted by bioinformatics as promiscuous HLA-DR ligands, and to the recombinant E6 protein. We found 3 donors with CD4+ T cells that specifically proliferated in the presence of HPV-18 E6 antigens and produced IFN-γ in the presence of the E6 protein. We then propagated CD4+ T cell lines and clones from the responsive subjects to better characterize the recognized sequences. We show that E652–66 and E697–111 are indeed promiscuous and, most importantly, they contain naturally processed epitopes. Collectively, our data indicate that healthy donors may develop spontaneous CD4 immunity against HPV-18 E6 epitopes, thus strongly suggesting the potential for this protein to elicit in the host a natural productive immune response.Keywords
This publication has 39 references indexed in Scilit:
- Disease-Stage Variance in Functional CD4+ T-Cell Responses Against Novel Pan-Human Leukocyte Antigen-D Region Presented Human Papillomavirus-16 E7 EpitopesClinical Cancer Research, 2004
- Prevention of cervical cancer through papillomavirus vaccinationNature Reviews Immunology, 2004
- Human papillomavirus type 16-specific T cell responses and their association with recurrence of cervical disease following treatmentJournal of General Virology, 2003
- Identification of immunodominant regions among promiscuous HLA-DR–restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3Blood, 2003
- Immune evasion in human papillomavirus-associated cervical cancerNature Reviews Cancer, 2002
- Persistence of Human Papillomavirus Type 16 Infection Is Associated with Lack of Cytotoxic T Lymphocyte Response to the E6 AntigensThe Journal of Infectious Diseases, 2000
- Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growthOncogene, 1997
- Sharing of Four DR‐β Sequence Motifs Between HLA‐DRB1*1601 and DRB1*1101 Correlates with Frequent Degenerate T‐Cell Recognition of HA306–320 Peptide Complexed to these Two MoleculesScandinavian Journal of Immunology, 1996
- Analysis of HLA‐DR expression on keratinocytes in cervical neoplasiaInternational Journal of Cancer, 1994
- Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cellsEuropean Journal of Immunology, 1989